Abstract

Summary

This paper synthesizes existing methods for evaluating the non-visual (circadian and neuroendocrine) effects of light into a unified framework applicable across diverse lighting solutions, standardizing concepts like spectral effectiveness factors and equivalent illuminance. For lighting designers and healthcare practitioners, it provides a consistent methodology to assess how different light spectra—particularly short-wavelength blue light—affect human health outcomes beyond visual function.
Abstract

Key Findings

  • Short-wavelength (blue) light is disproportionately effective at suppressing melatonin compared to longer-wavelength light, reflecting the spectral sensitivity of the novel ipRGC/melanopsin photoreceptor system.
  • The paper identifies and categorizes key concepts from existing literature (action spectra, spectral effectiveness factors, equivalent illuminance) to form an adaptable unified framework for non-visual lighting evaluation.
  • The framework is designed to be adaptable to a wide range of lighting solutions, bridging the gap between photobiological research and practical lighting design standards.
Categories

Categories

The Science of Light: Develops a unified framework for quantifying non-visual spectral effectiveness of light, incorporating melanopsin/ipRGC action spectra and concepts like equivalent illuminance and spectral effectiveness factors.
Sleep & Circadian Health: Directly addresses melatonin suppression and circadian entrainment as the primary non-visual outcomes used to evaluate spectral effectiveness of lighting.
Authors

Author(s)

ML Ámundadóttir, SW Lockley, M Andersen
Publication Date

Publication Year

2015
Citations

Number of Citations

9
View more publications